ethylisopropylamiloride has been researched along with phosphocreatine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albus, U; Englert, HC; Lang, HJ; Linz, W; Martorana, PA; Schölkens, BA; Scholz, W | 1 |
| Ramasamy, R; Schaefer, S | 2 |
3 other study(ies) available for ethylisopropylamiloride and phosphocreatine
| Article | Year |
|---|---|
Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia.
Topics: Adenosine Triphosphate; Amiloride; Anesthesia; Animals; Blood Platelets; Cattle; Endothelium, Vascular; Erythrocyte Membrane; Female; Glycogen; Guanidines; In Vitro Techniques; Ion Exchange; Male; Myocardial Ischemia; Phosphocreatine; Potassium; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium; Sulfones | 1993 |
Short-term inhibition of the Na-H exchanger limits acidosis and reduces ischemic injury in the rat heart.
Topics: Acidosis; Adenosine Triphosphate; Amiloride; Ammonium Chloride; Animals; Anti-Arrhythmia Agents; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Myocardial Ischemia; Myocardium; Perfusion; Phosphocreatine; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchangers; Time Factors | 1997 |
Inhibition of Na+-H+ exchanger protects diabetic and non-diabetic hearts from ischemic injury: insight into altered susceptibility of diabetic hearts to ischemic injury.
Topics: Acidosis; Adenosine Triphosphate; Amiloride; Animals; Calcium; Diabetes Mellitus, Type 1; Hydrogen-Ion Concentration; In Vitro Techniques; Intracellular Fluid; Magnetic Resonance Spectroscopy; Myocardial Reperfusion Injury; Phosphocreatine; Quaternary Ammonium Compounds; Rats; Rats, Inbred BB; Sodium; Sodium-Hydrogen Exchangers | 1999 |